Current technical development of magnetic resonance imaging

The impact of MRI continues to grow due to progress in all phases of the development cycle. Since its initial use for human imaging approximately 20 years ago, magnetic resonance imaging (MRI) has developed into a widely used clinical imaging modality. Now, at the start of the 21st century, the number of MRI systems worldwide is in excess of 10,800. With an average of over ten patients examined per day per machine, the number of clinical studies per day is well over 100,000. Along with X-ray imaging, ultrasound, computed X-ray tomography, and nuclear medicine, MRI is well recognized as a commonly used medical imaging modality. In spite of this significant growth over the last two decades, technical and application development continues. The purpose of this article is to identify the current development of MRI and to attempt to indicate future trends. In some sense this is an update of a similar technical assessment of MRI made four years ago     

US regulatory considerations for low field magnetic resonance imaging systems

Although there has been a resurgence of interest in low field magnetic resonance imaging (MRI) systems in recent years, low field MRI is not a new concept. FDA has a long history of evaluating the safety and effectiveness of MRI systems encompassing a wide range of field strengths. Many systems seeking marketing authorization today include new technological features (such as artificial intelligence), but this does not fundamentally change the regulatory paradigm for MR systems. In this review, we discuss some of the US regulatory considerations for low field magnetic resonance imaging (MRI) systems, including applicability of existing laws and regulations and how the U.S. Food and Drug Administration (FDA) evaluates low field MRI systems for market authorization. We also discuss regulatory considerations in the review of low field MRI systems incorporating novel AI technology. We foresee that MRI systems of all field strengths intended for general diagnostic use will continue to be evaluated for marketing clearance by the metric of substantial equivalence set forth in the premarket notification pathway.

     

Vessel wall characterization using quantitative MRI: what’s in a number?

The past decade has witnessed the rapid development of new MRI technology for vessel wall imaging. Today, with advances in MRI hardware and pulse sequences, quantitative MRI of the vessel wall represents a real alternative to conventional qualitative imaging, which is hindered by significant intra- and inter-observer variability. Quantitative MRI can measure several important morphological and functional characteristics of the vessel wall. This review provides a detailed introduction to novel quantitative MRI methods for measuring vessel wall dimensions, plaque composition and permeability, endothelial shear stress and wall stiffness. Together, these methods show the versatility of non-invasive quantitative MRI for probing vascular disease at several stages. These quantitative MRI biomarkers can play an important role in the context of both treatment response monitoring and risk prediction. Given the rapid developments in scan acceleration techniques and novel image reconstruction, we foresee the possibility of integrating the acquisition of multiple quantitative vessel wall parameters within a single scan session.     

Principles and methods for automatic and semi-automatic tissue segmentation in MRI data

The development of magnetic resonance imaging (MRI) revolutionized both the medical and scientific worlds. A large variety of MRI options have generated a huge amount of image data to interpret. The investigation of a specific tissue in 3D or 4D MR images can be facilitated by image processing techniques, such as segmentation and registration. In this work, we provide a brief review of the principles and methods that are commonly applied to achieve superior tissue segmentation results in MRI. The impacts of MR image acquisition on segmentation outcome and the principles of selecting and exploiting segmentation techniques tailored for specific tissue identification tasks are discussed. In the end, two exemplary applications, breast and fibroglandular tissue segmentation in MRI and myocardium segmentation in short-axis cine and real-time MRI, are discussed to explain the typical challenges that can be posed in practical segmentation tasks in MRI data. The corresponding solutions that are adopted to deal with these challenges of the two practical segmentation tasks are thoroughly reviewed.     

Faces and places [biomedical MRI pioneer]

MRI is now routinely used for medical diagnostics due to several inherent advantages over other imaging modalities. One major advantage of MRI is its safety and image quality. In contrast to conventional X-ray computer tomography, MRI does not use ionizing radiation so its use need not be limited by exposure concerns.     

Accuracy of computed tomography and magnetic resonance imaging in staging bronchogenic carcinoma

Sixty-three patients with non-small cell bronchogenic carcinoma were prospectively and independently assessed by computed tomography (CT) and magnetic resonance imaging (MRI) before surgery. Images were interpreted by four radiologists who had no knowledge of other imaging studies, except chest x-ray, and were blinded to surgical findings. The data were compared with pathologic and histologic findings. The accuracies of CT and MRI in determining tumor classification and assessing mediastinal and hilar lymph node metastases were compared. Sensitivity of CT in determining T factor was 78%, and specificity was 96%. The values for MRI were 84% and 96%, respectively. There was no significant difference between CT and MRI in staging tumors. MRI is more accurate than CT in diagnosing mediastinal invasion in staging superior sulcus tumors and complex tumors. There was no significant difference between the accuracies of CT and MRI in detecting mediastinal node metastases; the sensitivities were 82% and 90%, respectively, and specificities were 88% and 93%, respectively.     

An evolution of low-field strength MRI

The paper describes the evolution of low-field MRI from the very early pioneering days in the late 70 s until today. It is not meant to give a comprehensive historical account of the development of MRI, but rather to highlight the different research environments then and now. In the early 90 s, when low-field systems below 1.5 T essentially vanished, there were just no reasonable means available to make up for the factor of roughly three in signal-to-noise-ratio (SNR) between 0.5 and 1.5 T. This has drastically changed. Improvements in hardware—closed Helium-free magnets, RF receiver systems and especially much faster gradients, much more flexible sampling schemes including parallel imaging and compressed sensing and especially the use of AI at all stages of the imaging process have made low-field MRI a clinically viable supplement to conventional MRI. Ultralow-field MRI with magnets around 0.05 T are also back and constitute a bold and courageous endeavor to bring MRI to communities, which have neither the means nor the infrastructure to sustain a current standard of care MRI.

     

Artefacts in magnetic resonance imaging caused by dental material

A common problem in computer tomography (CT) based imaging of the oral cavity is artefacts caused by dental restorations. The aim of this study was to investigate whether magnetic resonance imaging (MRI) of the oral cavity would be less affected than CT by artefacts caused by typical dental restorative alloys. In order to assess the extent of artefact generation, corresponding MRI scans of the same anatomic region with and without dental metal restorations were matched using a stereotactic frame. MRI imaging of the oral and maxillofacial region could be performed without reduction of the image quality by metallic dental restorations made from titanium, gold or amalgam. Dental restorations made from titanium, gold or amalgam did not reduce the image quality of the MRI sequence used in imaging of the oral and maxillofacial region for dental implant planning. In this respect MRI is superior to CT in implant planning.     

核磁共振成像超导主磁体设计及分析

本文论述了不同结构的核磁共振成像超导主磁体设计的原理与计算机算法。编出的设计程序考虑了超导体的超导特性、磁场均匀性要求、磁体的经济性以及磁体结构选择等各方面的因素。用此程序对一系列具有不同磁体结构、不同中心场强、不同孔径要求的MRI超导主磁体进行设计计算及分析,获得了一些对实际设计MRI超导主磁体有参考价值的数据。此外,该程序还适用于其它具有圆柱对称性的高均匀度超导磁体的设计计算。     

A brief review of hardware for catheter tracking in magnetic resonance imaging.

Magnetic resonance imaging (MRI) has traditionally been used exclusively in a role for patient diagnosis. However, it is unlikely that this role is sufficient for its continued prominence in medical imaging. Instead, the more ambitious role in diagnosis and also therapy/intervention will occur as demand for minimally invasive procedures increases. Fortunately, with recent improvement in technical specifications and creative pulse sequence design, MRI systems can now provide high quality near-real-time images that facilitate a variety of image-guided procedures, many based around delivery via catheters. While X-ray opacity is not available as a means for detecting the progression of the catheter in MRI systems today, a variety of novel hardware devices have been designed and used for MRI catheter tracking. This report provides a brief review of some fundamental methods for catheter tracking in MRI.     

Detection of myocardial viability in acute infarction using contrast-enhanced <Superscript>1</Superscript>H magnetic resonance imaging

Background Reperfusion strategies salvage myocardium at risk in acute myocardial infarction (MI). This clinical study was performed to determine whether areas without evidence of delayed MRI contrast enhancement in MI correspond to viability by means of percent systolic wall thickening (%SWT) and enddiastolic wall thickness (EDWT) in chronic infarction. Methods Twenty MRI studies were performed in ten patients within 6 days of MI and 3 months post-MI. On a segmental basis the percentage of viable myocardium as defined by contrast-enhanced MRI (no delayed MRI contrast enhancement) in acute MI was measured and was compared with %SWT and EDWT in chronic MI. Results Of the 1718 segments in acute infarction in which the percentage of viable myocardium was measured 1333 were found to be completely viable by means of contrast-enhanced MRI (no delayed MRI contrast enhancement). All of these segments revealed %SWT on day 90 post-MI, and 97% of segments were viable by means of an EDWT of more than 5.5 mm. In 85 segments the proportion of viable myocardium was 50–99% (mean 56±8%), with 92% segments found to be viable by means of %SWT and 92% by EDWT, and of 156 segments with viable myocardium between 1–49% (36±8%) 79% were found to be viable by means of %SWT and 82% by EDWT. Corresponding proportions of 144 segments with transmural delayed MRI contrast enhancement in acute MI were 45% and 17%. Conclusions In acute reperfused MI viable myocardium as delineated by contrast-enhanced MRI is correlated with clinical parameters of viability. Delayed MRI contrast enhancement resolves nontransmural MI and may become a valuable clinical tool when planning revascularization procedures.     

Comparison between MRI, microbiology and histology in evaluation of antibiotics in a murine model of thigh infection

Although in vivo magnetic resonance imaging (MRI) is rapidly becoming a recognised tool in experimental pharmacological research, at the best of our knowledge, scarce application in the field of antibacterial drug research has been reported so far. In this last field, animal models of bacterial infections are used to test the efficacy of novel compounds. In this paper we have explored the potential usefulness of MRI in monitoring the chronological evolution of experimental bacterial infections and the effect of different therapeutic treatments. A murine model of thigh infection induced byStaphylococcus aureus has been used and the efficacy of vancomycin and imipenem/cilastatin has been tested. Three groups of infected animals were studied by microbiology, histology and MRI methods. The results obtained show that in vivo MRI data are highly consistent with microbiological and histological data, allowing, similarly to these commonly used techniques, the efficacy of different antibacterial treatments to be quantified. Our findings suggest that MRI could be used to assess the efficacy of new chemical entities in antibacterial pharmacological research. The advantages of MRI, as a non invasive technique, in comparison with commonly used microbiological and histological methods are discussed.     

Can sodium MRI be used as a method for mapping of cartilage stiffness?

Objective

Sodium concentration is responsible for (at least part of) the stiffness of articular cartilage due to the osmotic pressure it generates. Therefore, we hypothesized that we could use sodium MRI to approximate the stiffness of cartilage to assess early cartilage degeneration.

Methods

Four human tibial plateaus were retrieved from patients undergoing total knee replacement (TKR), and their cartilage stiffness mapped with indentation testing, after which samples were scanned in a 7 T MRI to determine sodium concentration. The relation of biomechanical parameters to MRI sodium and glycosaminoglycan (GAG) concentration was explored by a linear mixed model.

Results

Weak correlations of GAG concentration with apparent peak modulus (p?=?0.0057) and apparent equilibrium modulus (p?=?0.0181) were observed and lack of correlation of GAG concentration versus MRI sodium concentration was observed. MRI sodium concentration was not correlated with apparent peak modulus, though a moderate correlation of MRI sodium concentration with permeability was shown (p?=?0.0014).

Discussion and conclusion

Although there was correlation between GAG concentration and cartilage stiffness, this was not similar with sodium concentration as measured by MRI. Thus, if the correlation between MRI sodium imaging and GAG concentration could be resolved, this strategy for assessing cartilage functional quality still holds promise.

     

A brief review of hardware for catheter tracking in magnetic resonance imaging

Magnetic resonance imaging (MRI) has traditionally been used exclusively in a role for patient diagnosis. However, it is unlikely that this role is sufficient for its continued prominence in medical imaging. Instead, the more ambitious role in diagnosis and also therapy intervention will occur as demand for minimally invasive procedures increases. Fortunately, with recent improvement in technical specifications and creative pulse sequence design, MRI systems can now provide high quality near-real-time images that facilitate a variety of image-guided procedures, many based around delivery via catheters. While X-ray opacity is not available as a means for detecting the progression of the catheter in MRI systems today, a variety of novel hardware devices have been designed and used for MRI catheter tracking. This report provides a brief review of some fundamental methods for catheter tracking in MRI. Submitted at the ISMRM Hardware Workshop held 23–25 February 2001 in Cleveland, OH, USA.     

Magnetic resonance imaging and67ga scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma: a prospective pilot study

Purpose: To assess the potential value of magnetic resonance imaging (MRI) combined with⁶⁷Ga single-photon emission computed tomography (SPECT) versus computed tomography (CT) in the staging and in the monitoring of mediastinal malignant lymphoma. Materials and methods: Twenty-three patients, referred to our institute for the evaluation of lymphoma, underwent CT,⁶⁷Ga scan, and MRI between April 1993 and February 1996 at sequential intervals. The tests studied (MRI,^67Ga, and CT) were performed according to the following schedule: 1) before start of therapy; 2) after four courses of chemotherapy; and 3) 2, 6, 12, and 18 months after the end of treatment. Results: All patients studied at the time of diagnosis had abnormal gallium accumulation in the mediastinum as well as pathologic CT and pathologic signal intensity at MRI. Six months after the end of treatment full consistency was found between the results of MRI and SPECT, whereas during treatment and 2 months after the end of therapy MRI and⁶⁷Ga scan were not in agreement in nine patients. In the 23 patients in follow-up, in CT there were nine false-positive and three false-negative findings; in SPECT three false negatives; in MRI one false positive and one false negative. Conclusion: MRI can give morphologic information similar to CT, even superior due to multiplanarity and with major precision in the distinction between fibrosis and active disease. MRI is thus an alternative to CT. The association with SPECT allows a great diagnostic accuracy in the positive and negative predictive value.     

Long-term follow-up of patients with acute myocarditis by magnetic resonance imaging

Magnetic resonance imaging (MRI) reveals cardiac signal intensity changes in patients with acute myocarditis; however, the natural history of these changes and their relationship to individual outcomes are unknown. The relationship of MRI findings to long-term outcome was studied by serial MRI studies in 16 patients with acute myocarditis who were followed for 30±4 (SE) months. Myocardial contrast enhancement was monitored using contrast-enhanced T1-weighted fast spin-echo images. Left ventricular ejection fraction was measured with gradient-echo sequences. Clinical symptoms were scored. The results were compared to a control group of 26 age-matched, healthy volunteers. Myocardial contrast enhancement, which was markedly increased in the early course of the disease, decreased at 4 weeks and remained within the normal range in most patients after 30 months. Contrast enhancement 4 weeks after onset of symptoms was predictive for the functional and clinical long-term outcome. Contrast-enhanced MRI may be a useful, noninvasive tool for long-term follow-up of patients with acute myocarditis. Furthermore, relatively early MRI findings may predict longer-term outcomes. Electronic Publication     

结合分水岭算法和WKFCM算法的MRI图像分割

针对传统分水岭算法对MRI图像过分割的缺点,提出了一种基于分水岭算法和改进核聚类算法的MRI图像分割新方法.首先,通过传统的分水岭分割算法将MRI图像分割成不同的区域,然后根据改进的核聚类算法,利用Mercer核将各个区域的平均灰度值映射到高维特征空间,使得原来未显示出来的特征显现出来.这样就可以实现更准确的聚类,用灰...     

PET/MRI in cancer patients: first experiences and vision from Copenhagen

Combined PET/MRI systems are now commercially available and are expected to change the medical imaging field by providing combined anato-metabolic image information. We believe this will be of particular relevance in imaging of cancer patients. At the Department of Clinical Physiology, Nuclear Medicine & PET at Rigshospitalet in Copenhagen we installed an integrated PET/MRI in December 2011. Here, we describe our first clinical PET/MR cases and discuss some of the areas within oncology where we envision promising future application of integrated PET/MR imaging in clinical routine. Cases described include brain tumors, pediatric oncology as well as lung, abdominal and pelvic cancer. In general the cases show that PET/MRI performs well in all these types of cancer when compared to PET/CT. However, future large-scale clinical studies are needed to establish when to use PET/MRI. We envision that PET/MRI in oncology will prove to become a valuable addition to PET/CT in diagnosing, tailoring and monitoring cancer therapy in selected patient populations.     

Fluorine polymer probes for magnetic resonance imaging: quo vadis?

Over the last few years, the development and relevance of ¹⁹F magnetic resonance imaging (MRI) for use in clinical practice has emerged. MRI using fluorinated probes enables the achievement of a specific signal with high contrast in MRI images. However, to ensure sufficient sensitivity of ¹⁹F MRI, fluorine probes with a high content of chemically equivalent fluorine atoms are required. The majority of ¹⁹F MRI agents are perfluorocarbon emulsions, which have a broad range of applications in molecular imaging, although the content of fluorine atoms in these molecules is limited. In this review, we focus mainly on polymer probes that allow higher fluorine content and represent versatile platforms with properties tailorable to a plethora of biomedical in vivo applications. We discuss the chemical development, up to the first imaging applications, of these promising fluorine probes, including injectable polymers that form depots that are intended for possible use in cancer therapy.

     

The role of MRI in prostate cancer: current and future directions

Magnetic Resonance Materials in Physics, Biology and Medicine - There has been an increasing role of magnetic resonance imaging (MRI) in the management of prostate cancer. MRI already plays an...